A Computational Assay of Estrogen Receptor α Antagonists Reveals the Key Common Structural Traits of Drugs Effectively Fighting Refractory Breast Cancers
Matic Pavlin(Scuola Internazionale Superiore di Studi Avanzati), Alessandra Magistrato(Scuola Internazionale Superiore di Studi Avanzati), Marzia Pennati(Fondazione IRCCS Istituto Nazionale dei Tumori), Giorgio Colombo(University of Pavia), Alessandra Bisi(University of Bologna), Silvia Gobbi(University of Bologna), Nadia Zaffaroni(Fondazione IRCCS Istituto Nazionale dei Tumori), Angelo Spinello(University of Palermo)
Cited by 64
Related Papers
Isolation and <i>In vitro</i> Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties
|Cancer Research|2005|1.7k
Human Bone Marrow–Derived Mesenchymal Stem Cells Do Not Undergo Transformation after Long-term<i>In vitro</i>Culture and Do Not Exhibit Telomere Maintenance Mechanisms
|Cancer Research|2007|702
miR-205 Exerts Tumor-Suppressive Functions in Human Prostate through Down-regulation of Protein Kinase Cε
|Cancer Research|2009|363
Rational design of shepherdin, a novel anticancer agent
|Cancer Cell|2005|348
Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer
|Cellular and Molecular Life Sciences|2002|274